Inflammatory response time course, HUVEC (Wada, 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
WT1
|
ENSG00000184937.16 | WT1 |
MTF1
|
ENSG00000188786.10 | MTF1 |
ZBTB7B
|
ENSG00000160685.13 | ZBTB7B |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MTF1 | hg38_v1_chr1_-_37859583_37859609 | -0.57 | 2.9e-03 | Click! |
WT1 | hg38_v1_chr11_-_32435360_32435419 | -0.34 | 9.4e-02 | Click! |
ZBTB7B | hg38_v1_chr1_+_155002630_155002689 | -0.19 | 3.6e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_+_41360759 | 14.82 |
ENST00000508501.5
ENST00000512946.5 ENST00000313860.11 ENST00000512632.5 ENST00000512820.5 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr3_+_37861926 | 13.15 |
ENST00000443503.6
|
CTDSPL
|
CTD small phosphatase like |
chr9_+_136712531 | 11.97 |
ENST00000371692.9
|
DIPK1B
|
divergent protein kinase domain 1B |
chr3_+_37861849 | 11.93 |
ENST00000273179.10
|
CTDSPL
|
CTD small phosphatase like |
chr1_+_25616780 | 11.07 |
ENST00000374332.9
|
MAN1C1
|
mannosidase alpha class 1C member 1 |
chr1_+_61082553 | 9.52 |
ENST00000403491.8
ENST00000371187.7 |
NFIA
|
nuclear factor I A |
chr1_+_61082398 | 9.42 |
ENST00000664149.1
|
NFIA
|
nuclear factor I A |
chr18_+_79395856 | 8.16 |
ENST00000253506.9
ENST00000591814.5 ENST00000427363.7 |
NFATC1
|
nuclear factor of activated T cells 1 |
chr14_-_105168753 | 8.04 |
ENST00000331782.8
ENST00000347004.2 |
JAG2
|
jagged canonical Notch ligand 2 |
chr18_+_79400274 | 7.62 |
ENST00000545796.5
ENST00000318065.9 ENST00000592223.5 ENST00000329101.8 ENST00000586434.1 |
NFATC1
|
nuclear factor of activated T cells 1 |
chr2_+_6917404 | 7.47 |
ENST00000320892.11
|
RNF144A
|
ring finger protein 144A |
chr1_+_203305510 | 6.93 |
ENST00000290551.5
|
BTG2
|
BTG anti-proliferation factor 2 |
chr1_+_61082702 | 6.87 |
ENST00000485903.6
ENST00000371185.6 ENST00000371184.6 |
NFIA
|
nuclear factor I A |
chr17_+_83079595 | 6.76 |
ENST00000320095.12
|
METRNL
|
meteorin like, glial cell differentiation regulator |
chr8_+_1763752 | 6.74 |
ENST00000519254.2
|
CLN8
|
CLN8 transmembrane ER and ERGIC protein |
chr18_+_11981488 | 6.59 |
ENST00000269159.8
|
IMPA2
|
inositol monophosphatase 2 |
chr12_+_53046969 | 6.56 |
ENST00000379902.7
|
TNS2
|
tensin 2 |
chr8_+_1763832 | 6.38 |
ENST00000520991.3
|
CLN8
|
CLN8 transmembrane ER and ERGIC protein |
chr16_+_81444799 | 6.33 |
ENST00000537098.8
|
CMIP
|
c-Maf inducing protein |
chr7_+_74658004 | 6.31 |
ENST00000443166.5
|
GTF2I
|
general transcription factor IIi |
chr3_+_39809602 | 6.13 |
ENST00000302541.11
ENST00000396217.7 |
MYRIP
|
myosin VIIA and Rab interacting protein |
chr11_-_2885728 | 6.04 |
ENST00000647251.1
ENST00000380725.2 ENST00000430149.3 ENST00000414822.8 ENST00000440480.8 |
CDKN1C
|
cyclin dependent kinase inhibitor 1C |
chr14_+_24398986 | 5.96 |
ENST00000382554.4
|
NYNRIN
|
NYN domain and retroviral integrase containing |
chr13_-_106535653 | 5.88 |
ENST00000646441.1
|
EFNB2
|
ephrin B2 |
chr12_+_122835426 | 5.82 |
ENST00000253083.9
|
HIP1R
|
huntingtin interacting protein 1 related |
chr7_-_156892987 | 5.79 |
ENST00000415428.5
|
LMBR1
|
limb development membrane protein 1 |
chr8_+_27633863 | 5.78 |
ENST00000337221.8
|
SCARA3
|
scavenger receptor class A member 3 |
chr13_-_109786567 | 5.77 |
ENST00000375856.5
|
IRS2
|
insulin receptor substrate 2 |
chr2_+_111898592 | 5.75 |
ENST00000295408.9
ENST00000421804.6 ENST00000616902.4 ENST00000409780.5 |
MERTK
|
MER proto-oncogene, tyrosine kinase |
chr10_+_35127162 | 5.74 |
ENST00000354759.7
|
CREM
|
cAMP responsive element modulator |
chr21_+_17513003 | 5.68 |
ENST00000284878.12
ENST00000400166.5 |
CXADR
|
CXADR Ig-like cell adhesion molecule |
chr2_+_12716893 | 5.56 |
ENST00000381465.2
ENST00000155926.9 |
TRIB2
|
tribbles pseudokinase 2 |
chr20_+_43914801 | 5.44 |
ENST00000341197.9
|
TOX2
|
TOX high mobility group box family member 2 |
chr19_-_18941117 | 5.36 |
ENST00000600077.5
|
HOMER3
|
homer scaffold protein 3 |
chr9_-_14314567 | 5.36 |
ENST00000397579.6
|
NFIB
|
nuclear factor I B |
chr19_-_18941184 | 5.29 |
ENST00000594794.5
ENST00000392351.8 ENST00000596482.5 |
HOMER3
|
homer scaffold protein 3 |
chr10_-_124092445 | 5.20 |
ENST00000346248.7
|
CHST15
|
carbohydrate sulfotransferase 15 |
chr14_-_53953415 | 5.20 |
ENST00000559501.1
ENST00000558984.1 |
BMP4
|
bone morphogenetic protein 4 |
chr3_-_18424533 | 5.18 |
ENST00000417717.6
|
SATB1
|
SATB homeobox 1 |
chr2_+_46297397 | 5.13 |
ENST00000263734.5
|
EPAS1
|
endothelial PAS domain protein 1 |
chr18_+_79395942 | 5.10 |
ENST00000397790.6
|
NFATC1
|
nuclear factor of activated T cells 1 |
chr9_-_14322320 | 5.04 |
ENST00000606230.2
|
NFIB
|
nuclear factor I B |
chr2_+_48530132 | 5.02 |
ENST00000404752.6
ENST00000406226.1 |
STON1
|
stonin 1 |
chr4_+_42397473 | 5.00 |
ENST00000319234.5
|
SHISA3
|
shisa family member 3 |
chr10_-_79445617 | 4.96 |
ENST00000372336.4
|
ZCCHC24
|
zinc finger CCHC-type containing 24 |
chr22_+_50674879 | 4.91 |
ENST00000262795.6
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3 |
chr3_-_64445396 | 4.83 |
ENST00000295902.11
|
PRICKLE2
|
prickle planar cell polarity protein 2 |
chr15_+_57376497 | 4.66 |
ENST00000281282.6
|
CGNL1
|
cingulin like 1 |
chr8_-_80171106 | 4.56 |
ENST00000519303.6
|
TPD52
|
tumor protein D52 |
chr18_+_62325269 | 4.53 |
ENST00000639222.1
ENST00000269485.11 ENST00000616710.4 ENST00000617039.4 |
TNFRSF11A
|
TNF receptor superfamily member 11a |
chr13_+_20703677 | 4.47 |
ENST00000682841.1
|
IL17D
|
interleukin 17D |
chr17_+_63477052 | 4.36 |
ENST00000290866.10
ENST00000428043.5 |
ACE
|
angiotensin I converting enzyme |
chr20_-_48827992 | 4.33 |
ENST00000371941.4
|
PREX1
|
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 |
chr16_-_30096170 | 4.33 |
ENST00000566134.5
ENST00000565110.5 ENST00000398841.6 ENST00000398838.8 |
YPEL3
|
yippee like 3 |
chr20_+_36154630 | 4.32 |
ENST00000338074.7
ENST00000636016.2 ENST00000373945.5 |
EPB41L1
|
erythrocyte membrane protein band 4.1 like 1 |
chr9_-_78031775 | 4.32 |
ENST00000286548.9
|
GNAQ
|
G protein subunit alpha q |
chr9_-_75088198 | 4.30 |
ENST00000376808.8
|
NMRK1
|
nicotinamide riboside kinase 1 |
chr12_+_96194501 | 4.27 |
ENST00000552142.5
|
ELK3
|
ETS transcription factor ELK3 |
chr19_-_291365 | 4.27 |
ENST00000591572.2
ENST00000269812.7 ENST00000633125.1 ENST00000434325.7 |
PLPP2
|
phospholipid phosphatase 2 |
chr9_-_75088140 | 4.26 |
ENST00000361092.9
ENST00000376811.5 |
NMRK1
|
nicotinamide riboside kinase 1 |
chr8_-_47738153 | 4.26 |
ENST00000408965.4
|
CEBPD
|
CCAAT enhancer binding protein delta |
chr9_-_14314132 | 4.24 |
ENST00000380953.6
|
NFIB
|
nuclear factor I B |
chr7_+_74657745 | 4.21 |
ENST00000614986.4
ENST00000620879.4 ENST00000621734.4 |
GTF2I
|
general transcription factor IIi |
chr5_+_69492767 | 4.18 |
ENST00000681041.1
ENST00000680098.1 ENST00000680784.1 ENST00000396442.7 ENST00000681895.1 |
OCLN
|
occludin |
chr22_+_19714450 | 4.18 |
ENST00000455784.7
ENST00000406395.5 |
SEPTIN5
|
septin 5 |
chr1_-_231040218 | 4.17 |
ENST00000366654.5
|
FAM89A
|
family with sequence similarity 89 member A |
chr4_+_6269869 | 4.17 |
ENST00000506362.2
|
WFS1
|
wolframin ER transmembrane glycoprotein |
chr19_-_291132 | 4.15 |
ENST00000327790.7
|
PLPP2
|
phospholipid phosphatase 2 |
chr21_+_6111123 | 4.15 |
ENST00000613488.3
|
SIK1B
|
salt inducible kinase 1B (putative) |
chr10_+_35127023 | 4.13 |
ENST00000429130.7
ENST00000469949.6 ENST00000460270.5 |
CREM
|
cAMP responsive element modulator |
chr21_-_43427131 | 4.11 |
ENST00000270162.8
|
SIK1
|
salt inducible kinase 1 |
chr10_+_35126791 | 4.10 |
ENST00000474362.5
ENST00000374721.7 |
CREM
|
cAMP responsive element modulator |
chr14_+_56118404 | 4.09 |
ENST00000267460.9
|
PELI2
|
pellino E3 ubiquitin protein ligase family member 2 |
chr7_-_38631356 | 4.09 |
ENST00000356264.7
ENST00000325590.9 |
AMPH
|
amphiphysin |
chr9_-_14314067 | 4.07 |
ENST00000397575.7
|
NFIB
|
nuclear factor I B |
chr22_-_37519349 | 4.06 |
ENST00000251973.10
|
CARD10
|
caspase recruitment domain family member 10 |
chr18_+_11981548 | 4.06 |
ENST00000588927.5
|
IMPA2
|
inositol monophosphatase 2 |
chr22_+_19760714 | 4.05 |
ENST00000649276.2
|
TBX1
|
T-box transcription factor 1 |
chr14_+_61321571 | 4.05 |
ENST00000332981.11
|
PRKCH
|
protein kinase C eta |
chr8_-_28386073 | 4.03 |
ENST00000523095.5
ENST00000522795.1 |
ZNF395
|
zinc finger protein 395 |
chr9_-_13279407 | 4.01 |
ENST00000546205.5
|
MPDZ
|
multiple PDZ domain crumbs cell polarity complex component |
chr13_-_100674774 | 3.98 |
ENST00000328767.9
|
TMTC4
|
transmembrane O-mannosyltransferase targeting cadherins 4 |
chr22_-_37519528 | 3.96 |
ENST00000403299.5
|
CARD10
|
caspase recruitment domain family member 10 |
chr12_+_2959296 | 3.94 |
ENST00000358409.7
ENST00000359864.8 ENST00000540314.2 ENST00000536826.2 |
TEAD4
|
TEA domain transcription factor 4 |
chr7_-_87059639 | 3.93 |
ENST00000450689.7
|
ELAPOR2
|
endosome-lysosome associated apoptosis and autophagy regulator family member 2 |
chr2_-_164621461 | 3.93 |
ENST00000446413.6
ENST00000263915.8 |
GRB14
|
growth factor receptor bound protein 14 |
chr9_-_137302264 | 3.90 |
ENST00000356628.4
|
NRARP
|
NOTCH regulated ankyrin repeat protein |
chr1_-_21937300 | 3.90 |
ENST00000374695.8
|
HSPG2
|
heparan sulfate proteoglycan 2 |
chr6_+_17393657 | 3.89 |
ENST00000493172.5
ENST00000465994.5 |
CAP2
|
cyclase associated actin cytoskeleton regulatory protein 2 |
chr11_-_33869816 | 3.88 |
ENST00000395833.7
|
LMO2
|
LIM domain only 2 |
chr6_+_15248855 | 3.87 |
ENST00000397311.4
|
JARID2
|
jumonji and AT-rich interaction domain containing 2 |
chr9_-_14314519 | 3.87 |
ENST00000397581.6
|
NFIB
|
nuclear factor I B |
chr18_-_25352116 | 3.85 |
ENST00000584787.5
ENST00000538137.6 ENST00000361524.8 |
ZNF521
|
zinc finger protein 521 |
chr13_-_100674813 | 3.82 |
ENST00000376234.7
ENST00000423847.1 |
TMTC4
|
transmembrane O-mannosyltransferase targeting cadherins 4 |
chr1_-_91886144 | 3.82 |
ENST00000212355.9
|
TGFBR3
|
transforming growth factor beta receptor 3 |
chr1_+_61081728 | 3.81 |
ENST00000371189.8
|
NFIA
|
nuclear factor I A |
chr6_-_83709141 | 3.80 |
ENST00000521743.5
|
SNAP91
|
synaptosome associated protein 91 |
chr4_+_6269831 | 3.78 |
ENST00000503569.5
ENST00000673991.1 ENST00000682275.1 ENST00000226760.5 |
WFS1
|
wolframin ER transmembrane glycoprotein |
chr7_-_87059515 | 3.75 |
ENST00000423294.5
|
ELAPOR2
|
endosome-lysosome associated apoptosis and autophagy regulator family member 2 |
chr6_-_83709019 | 3.73 |
ENST00000519779.5
ENST00000369694.6 ENST00000195649.10 |
SNAP91
|
synaptosome associated protein 91 |
chr10_+_35127295 | 3.72 |
ENST00000489321.5
ENST00000427847.6 ENST00000374728.7 ENST00000345491.7 ENST00000487132.5 |
CREM
|
cAMP responsive element modulator |
chr14_+_105526568 | 3.68 |
ENST00000392519.7
|
TMEM121
|
transmembrane protein 121 |
chr9_-_136687422 | 3.67 |
ENST00000371696.7
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
chr2_+_190649062 | 3.66 |
ENST00000409581.5
ENST00000337386.10 |
NAB1
|
NGFI-A binding protein 1 |
chr2_+_60881553 | 3.63 |
ENST00000394479.4
|
REL
|
REL proto-oncogene, NF-kB subunit |
chr2_-_98731063 | 3.62 |
ENST00000393487.6
|
MGAT4A
|
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A |
chr9_+_2017383 | 3.61 |
ENST00000382194.6
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr9_-_136545997 | 3.60 |
ENST00000680133.1
ENST00000651671.1 ENST00000680668.1 ENST00000680218.1 |
NOTCH1
|
notch receptor 1 |
chr7_-_87059624 | 3.59 |
ENST00000444627.5
|
ELAPOR2
|
endosome-lysosome associated apoptosis and autophagy regulator family member 2 |
chr20_-_64049631 | 3.59 |
ENST00000340356.9
|
SOX18
|
SRY-box transcription factor 18 |
chr9_+_128552558 | 3.59 |
ENST00000372731.8
ENST00000630804.2 ENST00000372739.7 ENST00000627441.2 ENST00000358161.9 ENST00000636257.1 |
SPTAN1
|
spectrin alpha, non-erythrocytic 1 |
chr3_+_32238667 | 3.59 |
ENST00000458535.6
ENST00000307526.4 |
CMTM8
|
CKLF like MARVEL transmembrane domain containing 8 |
chr6_+_142301854 | 3.58 |
ENST00000230173.10
ENST00000367608.6 |
ADGRG6
|
adhesion G protein-coupled receptor G6 |
chr9_-_136687380 | 3.56 |
ENST00000538402.1
ENST00000371694.7 |
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
chr9_-_14313642 | 3.55 |
ENST00000637742.1
|
NFIB
|
nuclear factor I B |
chrX_+_9786420 | 3.54 |
ENST00000380913.8
|
SHROOM2
|
shroom family member 2 |
chr2_+_20667136 | 3.52 |
ENST00000272224.5
|
GDF7
|
growth differentiation factor 7 |
chr8_+_27633884 | 3.50 |
ENST00000301904.4
|
SCARA3
|
scavenger receptor class A member 3 |
chr5_+_69415065 | 3.49 |
ENST00000647531.1
ENST00000645446.1 ENST00000325631.10 ENST00000454295.6 |
MARVELD2
|
MARVEL domain containing 2 |
chr11_-_2139382 | 3.48 |
ENST00000416167.7
|
IGF2
|
insulin like growth factor 2 |
chr13_-_76886397 | 3.47 |
ENST00000377474.4
|
KCTD12
|
potassium channel tetramerization domain containing 12 |
chr11_+_59755427 | 3.47 |
ENST00000529177.5
|
STX3
|
syntaxin 3 |
chr4_+_1011595 | 3.47 |
ENST00000510644.6
|
FGFRL1
|
fibroblast growth factor receptor like 1 |
chr9_-_130043154 | 3.46 |
ENST00000355681.3
ENST00000446176.7 ENST00000443566.6 ENST00000420781.5 |
FNBP1
|
formin binding protein 1 |
chr20_-_40689228 | 3.45 |
ENST00000373313.3
|
MAFB
|
MAF bZIP transcription factor B |
chr14_+_96039328 | 3.45 |
ENST00000553764.1
ENST00000555004.3 ENST00000556728.1 ENST00000553782.1 |
C14orf132
|
chromosome 14 open reading frame 132 |
chr7_+_74657695 | 3.42 |
ENST00000573035.6
|
GTF2I
|
general transcription factor IIi |
chr6_+_142301926 | 3.41 |
ENST00000296932.13
ENST00000367609.8 |
ADGRG6
|
adhesion G protein-coupled receptor G6 |
chr1_-_207911027 | 3.37 |
ENST00000310833.12
|
CD34
|
CD34 molecule |
chr1_-_94541746 | 3.35 |
ENST00000334047.12
|
F3
|
coagulation factor III, tissue factor |
chr3_-_125055987 | 3.35 |
ENST00000311127.9
|
HEG1
|
heart development protein with EGF like domains 1 |
chr4_-_101347492 | 3.33 |
ENST00000394854.8
|
PPP3CA
|
protein phosphatase 3 catalytic subunit alpha |
chr6_+_17393505 | 3.31 |
ENST00000616440.4
|
CAP2
|
cyclase associated actin cytoskeleton regulatory protein 2 |
chr1_+_25543598 | 3.31 |
ENST00000374338.5
|
LDLRAP1
|
low density lipoprotein receptor adaptor protein 1 |
chr8_+_143734133 | 3.30 |
ENST00000527139.7
ENST00000533004.5 |
IQANK1
|
IQ motif and ankyrin repeat containing 1 |
chr12_+_57089094 | 3.30 |
ENST00000342556.6
ENST00000300131.8 |
NAB2
|
NGFI-A binding protein 2 |
chr6_+_17393576 | 3.29 |
ENST00000229922.7
ENST00000611958.4 |
CAP2
|
cyclase associated actin cytoskeleton regulatory protein 2 |
chr1_+_34792990 | 3.26 |
ENST00000450137.1
ENST00000342280.5 |
GJA4
|
gap junction protein alpha 4 |
chr11_-_119364166 | 3.22 |
ENST00000525735.1
|
USP2
|
ubiquitin specific peptidase 2 |
chr13_-_48533069 | 3.21 |
ENST00000344532.8
|
RCBTB2
|
RCC1 and BTB domain containing protein 2 |
chr19_-_14090963 | 3.21 |
ENST00000269724.5
|
SAMD1
|
sterile alpha motif domain containing 1 |
chr9_+_137077467 | 3.21 |
ENST00000409858.8
|
UAP1L1
|
UDP-N-acetylglucosamine pyrophosphorylase 1 like 1 |
chr3_+_58237501 | 3.21 |
ENST00000295962.8
|
ABHD6
|
abhydrolase domain containing 6, acylglycerol lipase |
chr7_+_80134794 | 3.20 |
ENST00000649796.2
|
GNAI1
|
G protein subunit alpha i1 |
chr1_+_64745089 | 3.18 |
ENST00000294428.7
ENST00000371072.8 |
RAVER2
|
ribonucleoprotein, PTB binding 2 |
chr20_-_23049659 | 3.17 |
ENST00000377103.3
|
THBD
|
thrombomodulin |
chr15_-_34367045 | 3.17 |
ENST00000617710.4
|
LPCAT4
|
lysophosphatidylcholine acyltransferase 4 |
chr22_+_44752552 | 3.16 |
ENST00000389774.6
ENST00000356099.11 ENST00000396119.6 ENST00000336963.8 ENST00000412433.5 |
ARHGAP8
|
Rho GTPase activating protein 8 |
chr7_-_149773207 | 3.15 |
ENST00000484747.5
|
ZNF467
|
zinc finger protein 467 |
chr8_-_38467701 | 3.15 |
ENST00000425967.8
ENST00000533668.5 ENST00000413133.6 ENST00000397108.8 ENST00000526742.5 ENST00000525001.5 ENST00000529552.5 ENST00000397113.6 |
FGFR1
|
fibroblast growth factor receptor 1 |
chr4_+_155667654 | 3.13 |
ENST00000513574.1
|
GUCY1A1
|
guanylate cyclase 1 soluble subunit alpha 1 |
chr8_-_73746830 | 3.13 |
ENST00000524300.6
ENST00000523558.5 ENST00000521210.5 ENST00000355780.9 ENST00000524104.5 ENST00000521736.5 ENST00000521447.5 ENST00000517542.5 ENST00000521451.5 ENST00000521419.5 ENST00000518502.5 |
STAU2
|
staufen double-stranded RNA binding protein 2 |
chr10_-_33335074 | 3.11 |
ENST00000432372.6
|
NRP1
|
neuropilin 1 |
chr1_+_78045956 | 3.08 |
ENST00000370759.4
|
GIPC2
|
GIPC PDZ domain containing family member 2 |
chr7_+_107044689 | 3.08 |
ENST00000265717.5
|
PRKAR2B
|
protein kinase cAMP-dependent type II regulatory subunit beta |
chr19_-_17245889 | 3.08 |
ENST00000291442.4
|
NR2F6
|
nuclear receptor subfamily 2 group F member 6 |
chr14_+_99793329 | 3.07 |
ENST00000334192.8
|
EML1
|
EMAP like 1 |
chrX_+_10015226 | 3.07 |
ENST00000380861.9
|
WWC3
|
WWC family member 3 |
chr12_+_3077355 | 3.07 |
ENST00000537971.5
ENST00000011898.10 ENST00000649909.1 |
TSPAN9
|
tetraspanin 9 |
chr1_-_234610169 | 3.06 |
ENST00000366609.4
|
IRF2BP2
|
interferon regulatory factor 2 binding protein 2 |
chr9_+_112750722 | 3.06 |
ENST00000374232.8
|
SNX30
|
sorting nexin family member 30 |
chr1_+_77532100 | 3.06 |
ENST00000478255.1
|
AK5
|
adenylate kinase 5 |
chr6_+_17393607 | 3.05 |
ENST00000489374.5
ENST00000378990.6 |
CAP2
|
cyclase associated actin cytoskeleton regulatory protein 2 |
chr1_-_94541636 | 3.03 |
ENST00000370207.4
|
F3
|
coagulation factor III, tissue factor |
chr6_-_13487593 | 3.03 |
ENST00000379287.4
ENST00000603223.1 |
GFOD1
|
glucose-fructose oxidoreductase domain containing 1 |
chr9_+_131096476 | 3.03 |
ENST00000372309.7
ENST00000247291.8 ENST00000372302.5 ENST00000372300.5 ENST00000372298.1 |
AIF1L
|
allograft inflammatory factor 1 like |
chr13_-_100674787 | 3.03 |
ENST00000342624.10
|
TMTC4
|
transmembrane O-mannosyltransferase targeting cadherins 4 |
chr3_-_171460063 | 3.03 |
ENST00000284483.12
ENST00000475336.5 ENST00000357327.9 ENST00000460047.5 ENST00000488470.5 ENST00000470834.5 |
TNIK
|
TRAF2 and NCK interacting kinase |
chr4_+_122826679 | 3.02 |
ENST00000264498.8
|
FGF2
|
fibroblast growth factor 2 |
chrX_+_150363306 | 3.02 |
ENST00000370401.7
ENST00000432680.7 |
MAMLD1
|
mastermind like domain containing 1 |
chr11_+_33376077 | 3.02 |
ENST00000658780.2
|
KIAA1549L
|
KIAA1549 like |
chr18_+_11981015 | 3.02 |
ENST00000589238.5
|
IMPA2
|
inositol monophosphatase 2 |
chr2_-_239400949 | 3.01 |
ENST00000345617.7
|
HDAC4
|
histone deacetylase 4 |
chr13_+_31846713 | 3.00 |
ENST00000645780.1
|
FRY
|
FRY microtubule binding protein |
chr18_+_62325294 | 3.00 |
ENST00000586569.3
|
TNFRSF11A
|
TNF receptor superfamily member 11a |
chr6_-_13486137 | 2.99 |
ENST00000612338.4
|
GFOD1
|
glucose-fructose oxidoreductase domain containing 1 |
chr3_+_58237773 | 2.99 |
ENST00000478253.6
|
ABHD6
|
abhydrolase domain containing 6, acylglycerol lipase |
chr20_+_11890785 | 2.99 |
ENST00000399006.6
ENST00000405977.5 |
BTBD3
|
BTB domain containing 3 |
chr2_+_241558716 | 2.99 |
ENST00000318407.5
|
BOK
|
BCL2 family apoptosis regulator BOK |
chr2_-_189580773 | 2.99 |
ENST00000261024.7
|
SLC40A1
|
solute carrier family 40 member 1 |
chr7_+_90211686 | 2.98 |
ENST00000287908.7
ENST00000394621.7 ENST00000394626.5 |
STEAP2
|
STEAP2 metalloreductase |
chr12_+_53050179 | 2.96 |
ENST00000546602.5
ENST00000552570.5 ENST00000549700.5 |
TNS2
|
tensin 2 |
chr4_+_155667198 | 2.95 |
ENST00000296518.11
|
GUCY1A1
|
guanylate cyclase 1 soluble subunit alpha 1 |
chr10_+_123135938 | 2.95 |
ENST00000357878.7
|
HMX3
|
H6 family homeobox 3 |
chr21_-_38660656 | 2.95 |
ENST00000398919.6
|
ERG
|
ETS transcription factor ERG |
chr10_+_110871789 | 2.95 |
ENST00000393104.6
|
PDCD4
|
programmed cell death 4 |
chr1_+_65525641 | 2.93 |
ENST00000344610.12
ENST00000616738.4 |
LEPR
|
leptin receptor |
chr19_-_11339573 | 2.92 |
ENST00000222120.8
|
RAB3D
|
RAB3D, member RAS oncogene family |
chr1_+_77281963 | 2.91 |
ENST00000354567.7
|
AK5
|
adenylate kinase 5 |
chr14_-_29927596 | 2.90 |
ENST00000415220.6
|
PRKD1
|
protein kinase D1 |
chrX_+_150363258 | 2.90 |
ENST00000683696.1
|
MAMLD1
|
mastermind like domain containing 1 |
chr1_+_94418375 | 2.90 |
ENST00000370214.9
|
ABCD3
|
ATP binding cassette subfamily D member 3 |
chr4_-_101347471 | 2.90 |
ENST00000323055.10
ENST00000512215.5 |
PPP3CA
|
protein phosphatase 3 catalytic subunit alpha |
chr12_+_93571832 | 2.90 |
ENST00000549887.1
|
SOCS2
|
suppressor of cytokine signaling 2 |
chr19_+_34254543 | 2.89 |
ENST00000588470.5
ENST00000299505.8 ENST00000589583.5 |
GARRE1
|
granule associated Rac and RHOG effector 1 |
chr2_+_60881515 | 2.89 |
ENST00000295025.12
|
REL
|
REL proto-oncogene, NF-kB subunit |
chr3_-_18425295 | 2.89 |
ENST00000338745.11
ENST00000450898.1 |
SATB1
|
SATB homeobox 1 |
chr21_+_45074549 | 2.88 |
ENST00000348831.9
ENST00000437626.5 ENST00000389863.8 |
ADARB1
|
adenosine deaminase RNA specific B1 |
chr7_-_32892015 | 2.88 |
ENST00000452926.1
|
KBTBD2
|
kelch repeat and BTB domain containing 2 |
chr5_-_111757704 | 2.86 |
ENST00000379671.7
|
NREP
|
neuronal regeneration related protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 12.8 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
3.0 | 15.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
2.8 | 30.5 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
2.7 | 8.0 | GO:1903892 | negative regulation of ATF6-mediated unfolded protein response(GO:1903892) |
2.6 | 10.6 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
2.5 | 7.5 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
2.3 | 13.8 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
2.2 | 6.7 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
2.2 | 6.6 | GO:0007037 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
2.1 | 8.6 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
2.1 | 8.5 | GO:1902378 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
2.1 | 6.3 | GO:0019413 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
2.0 | 8.2 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) |
1.9 | 5.7 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
1.9 | 13.0 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
1.8 | 7.4 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
1.8 | 1.8 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
1.8 | 3.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
1.7 | 1.7 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
1.7 | 12.0 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
1.7 | 5.1 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
1.6 | 6.6 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.6 | 4.9 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) |
1.6 | 1.6 | GO:0006083 | acetate metabolic process(GO:0006083) |
1.5 | 6.0 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.5 | 7.5 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
1.5 | 6.0 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
1.4 | 8.6 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
1.4 | 5.6 | GO:1903294 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
1.4 | 4.1 | GO:1902365 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
1.3 | 5.3 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
1.3 | 3.8 | GO:0097187 | dentinogenesis(GO:0097187) |
1.3 | 6.3 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
1.3 | 6.3 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
1.2 | 3.7 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
1.2 | 8.6 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.2 | 3.6 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.2 | 10.5 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
1.1 | 3.4 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
1.1 | 3.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
1.1 | 3.3 | GO:0015917 | aminophospholipid transport(GO:0015917) |
1.1 | 4.4 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
1.1 | 7.4 | GO:0030421 | defecation(GO:0030421) |
1.0 | 6.3 | GO:0051622 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
1.0 | 4.2 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
1.0 | 9.4 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
1.0 | 3.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.0 | 4.0 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
1.0 | 3.0 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
1.0 | 3.0 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
1.0 | 2.9 | GO:0061445 | endocardial cell fate commitment(GO:0060957) endocardial cushion cell fate commitment(GO:0061445) |
0.9 | 3.8 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.9 | 5.7 | GO:0038016 | insulin receptor internalization(GO:0038016) |
0.9 | 2.8 | GO:0051793 | medium-chain fatty acid catabolic process(GO:0051793) |
0.9 | 7.4 | GO:0003138 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.9 | 24.8 | GO:0072189 | ureter development(GO:0072189) |
0.9 | 2.7 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.9 | 1.8 | GO:0072011 | glomerular endothelium development(GO:0072011) |
0.9 | 10.6 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.9 | 6.0 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.9 | 5.1 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.9 | 2.6 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.9 | 4.3 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.8 | 5.0 | GO:0060214 | endocardium formation(GO:0060214) |
0.8 | 0.8 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.8 | 9.0 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.8 | 3.3 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
0.8 | 0.8 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.8 | 4.1 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.8 | 7.3 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.8 | 2.4 | GO:0034148 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
0.8 | 3.2 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.8 | 8.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.8 | 3.9 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) |
0.8 | 3.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.8 | 2.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.8 | 9.9 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.8 | 6.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.8 | 2.3 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.8 | 2.3 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.7 | 3.0 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.7 | 8.2 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
0.7 | 2.2 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.7 | 6.0 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.7 | 8.9 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.7 | 3.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.7 | 2.2 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.7 | 3.6 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.7 | 2.9 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.7 | 2.9 | GO:1904980 | positive regulation of endosome organization(GO:1904980) |
0.7 | 5.7 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.7 | 9.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.7 | 4.2 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.7 | 2.1 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
0.7 | 3.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.7 | 0.7 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.7 | 1.4 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.7 | 2.8 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.7 | 2.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.7 | 2.7 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.7 | 2.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.7 | 4.7 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.7 | 2.0 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
0.7 | 3.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.7 | 2.0 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.7 | 3.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.7 | 1.3 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.7 | 2.0 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.6 | 3.9 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.6 | 1.9 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.6 | 0.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.6 | 3.2 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.6 | 1.9 | GO:0036046 | protein demalonylation(GO:0036046) peptidyl-lysine demalonylation(GO:0036047) protein desuccinylation(GO:0036048) peptidyl-lysine desuccinylation(GO:0036049) protein deglutarylation(GO:0061698) peptidyl-lysine deglutarylation(GO:0061699) |
0.6 | 0.6 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.6 | 3.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.6 | 3.8 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.6 | 3.7 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.6 | 2.5 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.6 | 2.5 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.6 | 6.2 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.6 | 2.4 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.6 | 1.8 | GO:0033869 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
0.6 | 4.9 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.6 | 8.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.6 | 7.9 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.6 | 1.2 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.6 | 4.2 | GO:0097338 | response to clozapine(GO:0097338) |
0.6 | 5.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.6 | 1.8 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.6 | 3.6 | GO:0006574 | valine catabolic process(GO:0006574) |
0.6 | 3.6 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.6 | 1.8 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.6 | 4.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.6 | 2.3 | GO:1900276 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.6 | 3.5 | GO:0016129 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.6 | 2.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.6 | 5.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.6 | 1.7 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
0.6 | 1.7 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.6 | 1.7 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.6 | 1.7 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.6 | 7.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.6 | 1.7 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.6 | 2.2 | GO:0006272 | leading strand elongation(GO:0006272) |
0.6 | 0.6 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.6 | 1.7 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.5 | 2.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.5 | 1.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.5 | 11.5 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.5 | 1.6 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.5 | 2.7 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.5 | 1.6 | GO:0072229 | proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
0.5 | 1.1 | GO:0070662 | mast cell proliferation(GO:0070662) |
0.5 | 1.6 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.5 | 5.9 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.5 | 4.8 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.5 | 0.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.5 | 3.7 | GO:0060769 | positive regulation of epithelial cell proliferation involved in prostate gland development(GO:0060769) |
0.5 | 3.2 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.5 | 5.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 1.6 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.5 | 1.0 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
0.5 | 3.1 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.5 | 5.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.5 | 1.0 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.5 | 5.2 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.5 | 11.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.5 | 0.5 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.5 | 3.6 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.5 | 1.5 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.5 | 2.0 | GO:0009405 | pathogenesis(GO:0009405) |
0.5 | 0.5 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.5 | 2.0 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.5 | 2.5 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.5 | 2.5 | GO:0015862 | uridine transport(GO:0015862) |
0.5 | 1.5 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
0.5 | 1.5 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.5 | 1.0 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.5 | 1.4 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.5 | 1.4 | GO:0089709 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
0.5 | 1.4 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.5 | 0.9 | GO:0061141 | lung ciliated cell differentiation(GO:0061141) |
0.5 | 0.9 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.5 | 1.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.5 | 1.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.5 | 0.9 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.5 | 1.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.5 | 0.5 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.5 | 1.4 | GO:0060003 | copper ion export(GO:0060003) |
0.5 | 1.9 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.5 | 1.4 | GO:0042938 | dipeptide transport(GO:0042938) |
0.5 | 1.4 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.5 | 1.4 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.5 | 1.8 | GO:0061312 | BMP signaling pathway involved in heart development(GO:0061312) |
0.5 | 3.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.5 | 1.8 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.5 | 2.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.5 | 1.4 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.5 | 3.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.5 | 9.0 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.4 | 8.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 9.8 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.4 | 1.8 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.4 | 1.3 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
0.4 | 1.3 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.4 | 1.3 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.4 | 2.6 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.4 | 4.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 0.9 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.4 | 1.3 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.4 | 1.3 | GO:0019483 | beta-alanine biosynthetic process(GO:0019483) |
0.4 | 0.9 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.4 | 1.3 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.4 | 4.2 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.4 | 0.4 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.4 | 1.3 | GO:0051939 | gamma-aminobutyric acid import(GO:0051939) |
0.4 | 8.8 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.4 | 0.4 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.4 | 1.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.4 | 1.2 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
0.4 | 2.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 6.2 | GO:0015074 | DNA integration(GO:0015074) |
0.4 | 1.7 | GO:0009956 | radial pattern formation(GO:0009956) |
0.4 | 0.4 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.4 | 2.9 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.4 | 1.2 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.4 | 1.2 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.4 | 1.2 | GO:0050992 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
0.4 | 2.4 | GO:0033088 | regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.4 | 1.2 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.4 | 0.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.4 | 2.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.4 | 6.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 1.2 | GO:0031247 | actin rod assembly(GO:0031247) |
0.4 | 1.2 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.4 | 9.9 | GO:0009650 | UV protection(GO:0009650) |
0.4 | 2.8 | GO:1902075 | cellular response to salt(GO:1902075) |
0.4 | 1.2 | GO:0034963 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.4 | 0.8 | GO:0010042 | response to manganese ion(GO:0010042) |
0.4 | 2.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 0.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.4 | 1.6 | GO:0006311 | meiotic gene conversion(GO:0006311) |
0.4 | 5.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.4 | 11.7 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.4 | 0.8 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.4 | 1.5 | GO:1904448 | gamma-aminobutyric acid catabolic process(GO:0009450) negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.4 | 1.5 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.4 | 0.4 | GO:0033216 | ferric iron import(GO:0033216) |
0.4 | 2.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.4 | 2.3 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.4 | 2.7 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.4 | 1.9 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.4 | 1.1 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.4 | 4.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 4.9 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.4 | 1.1 | GO:1902617 | response to fluoride(GO:1902617) |
0.4 | 1.9 | GO:0019075 | virus maturation(GO:0019075) |
0.4 | 1.1 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
0.4 | 3.7 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.4 | 10.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 6.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.4 | 3.7 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.4 | 2.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.4 | 1.5 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.4 | 1.1 | GO:0031550 | positive regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031550) |
0.4 | 4.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.4 | 1.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.4 | 4.4 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.4 | 1.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.4 | 12.0 | GO:0014850 | response to muscle activity(GO:0014850) |
0.4 | 1.4 | GO:0009447 | putrescine catabolic process(GO:0009447) |
0.4 | 2.9 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) |
0.4 | 0.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.4 | 1.4 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.4 | 0.4 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.4 | 1.1 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.4 | 1.4 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.3 | 1.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.3 | 0.3 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.3 | 2.4 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.3 | 3.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.3 | 1.7 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.3 | 2.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.3 | 8.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 1.7 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.3 | 1.0 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.3 | 1.0 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.3 | 16.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.3 | 1.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.3 | 3.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.3 | 0.3 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.3 | 2.0 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.3 | 4.7 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.3 | 1.0 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.3 | 14.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 6.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.3 | 9.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.3 | 3.3 | GO:0045176 | apical protein localization(GO:0045176) |
0.3 | 1.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 4.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 5.2 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 0.6 | GO:2000984 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
0.3 | 4.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.3 | 2.2 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.3 | 2.5 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.3 | 1.6 | GO:0015853 | adenine transport(GO:0015853) |
0.3 | 0.3 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.3 | 0.9 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.3 | 1.3 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 1.9 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.3 | 0.6 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.3 | 4.4 | GO:0051593 | response to folic acid(GO:0051593) |
0.3 | 0.9 | GO:1903249 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.3 | 1.2 | GO:0048627 | myoblast development(GO:0048627) |
0.3 | 0.6 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
0.3 | 2.4 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.3 | 3.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.3 | 1.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 2.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 0.6 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.3 | 1.5 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) malonyl-CoA biosynthetic process(GO:2001295) |
0.3 | 1.8 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.3 | 1.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 1.8 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 0.9 | GO:0046108 | uridine metabolic process(GO:0046108) |
0.3 | 1.5 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.3 | 1.5 | GO:0038001 | paracrine signaling(GO:0038001) |
0.3 | 0.9 | GO:1901874 | negative regulation of post-translational protein modification(GO:1901874) |
0.3 | 0.9 | GO:0097274 | urea homeostasis(GO:0097274) |
0.3 | 4.1 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.3 | 4.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.3 | 0.6 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 0.9 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.3 | 1.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.3 | 0.9 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.3 | 0.6 | GO:0034758 | regulation of T cell antigen processing and presentation(GO:0002625) positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) |
0.3 | 6.7 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.3 | 1.2 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
0.3 | 1.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 5.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.3 | 0.3 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
0.3 | 2.8 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.3 | 1.1 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.3 | 0.3 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
0.3 | 0.8 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.3 | 0.8 | GO:1990922 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.3 | 1.4 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.3 | 0.8 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.3 | 2.2 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.3 | 0.6 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.3 | 1.7 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.3 | 1.7 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.3 | 2.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 2.2 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.3 | 0.8 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.3 | 2.7 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.3 | 0.3 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.3 | 1.1 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.3 | 4.3 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.3 | 1.4 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.3 | 1.1 | GO:0016334 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.3 | 0.8 | GO:0032417 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.3 | 0.8 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
0.3 | 0.8 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 1.6 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.3 | 0.3 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.3 | 0.5 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.3 | 0.8 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.3 | 1.1 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.3 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.3 | 1.3 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.3 | 5.5 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.3 | 1.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 1.0 | GO:0018032 | protein amidation(GO:0018032) |
0.3 | 1.6 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.3 | 1.3 | GO:0034959 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.3 | 0.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.3 | 0.3 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.3 | 0.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 0.5 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.3 | 4.6 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.3 | 2.6 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.3 | 0.3 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
0.3 | 1.0 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.3 | 4.6 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.3 | 1.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 1.8 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.3 | 5.6 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.3 | 0.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.3 | 1.8 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 5.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.2 | GO:0032902 | nerve growth factor production(GO:0032902) |
0.2 | 0.7 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.2 | 1.0 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 6.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 4.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 4.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 5.9 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.2 | 1.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 1.7 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 2.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 1.0 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.2 | 0.2 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.2 | 0.2 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.2 | 1.5 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
0.2 | 1.0 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.2 | 2.9 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 1.4 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.2 | 4.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 1.2 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.2 | 1.0 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.2 | 1.2 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.2 | 0.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 0.5 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
0.2 | 1.4 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.2 | 0.5 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.2 | 0.7 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) positive regulation of opsonization(GO:1903028) |
0.2 | 0.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 0.2 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.2 | 0.7 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.2 | 3.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 2.3 | GO:0046689 | response to mercury ion(GO:0046689) |
0.2 | 0.2 | GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051343) |
0.2 | 0.7 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.2 | 5.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.2 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.2 | 0.7 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.2 | 0.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.2 | 1.8 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.2 | 0.2 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.2 | 1.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 1.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.2 | 1.3 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.2 | 12.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 1.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 1.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 0.2 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.2 | 0.7 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
0.2 | 0.9 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.2 | 2.9 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 2.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 1.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 2.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 1.8 | GO:1904177 | regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
0.2 | 0.9 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.2 | 0.7 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 1.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 11.4 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 2.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 0.4 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
0.2 | 4.8 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 0.6 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 1.1 | GO:0007143 | female meiotic division(GO:0007143) |
0.2 | 0.4 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
0.2 | 0.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 0.8 | GO:0090647 | modulation of age-related behavioral decline(GO:0090647) |
0.2 | 0.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.2 | 0.6 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.2 | 0.8 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 0.8 | GO:0009305 | protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
0.2 | 1.5 | GO:0045073 | regulation of chemokine biosynthetic process(GO:0045073) |
0.2 | 0.4 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.2 | 2.7 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.2 | 0.6 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
0.2 | 2.1 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 0.4 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.2 | 1.0 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 2.7 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.2 | 0.4 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.2 | 0.4 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.2 | 1.2 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.2 | 1.7 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.2 | 1.2 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.2 | 4.1 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.2 | 0.6 | GO:0006683 | galactosylceramide catabolic process(GO:0006683) |
0.2 | 0.4 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.2 | 0.4 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.2 | 0.6 | GO:0071529 | cementum mineralization(GO:0071529) |
0.2 | 1.0 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
0.2 | 1.0 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.2 | 1.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 6.7 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.2 | 0.6 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 2.0 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.2 | 0.6 | GO:0032679 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.2 | 0.6 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.2 | 1.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 0.8 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.2 | 4.8 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.2 | 1.4 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.2 | 0.6 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.2 | 1.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 1.4 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 0.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.2 | 2.5 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.2 | 1.9 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 10.5 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.2 | 1.2 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.2 | 1.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 7.7 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.2 | 11.0 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.2 | 4.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 3.5 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.2 | 0.8 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.2 | 0.6 | GO:0046543 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
0.2 | 2.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 7.7 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.2 | 0.6 | GO:0019878 | lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
0.2 | 0.6 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.2 | 0.6 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
0.2 | 1.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.2 | 0.6 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 0.6 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.2 | 0.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.2 | 1.1 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) |
0.2 | 0.6 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.2 | 1.3 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 0.8 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 0.2 | GO:0046601 | positive regulation of centrosome duplication(GO:0010825) positive regulation of centriole replication(GO:0046601) |
0.2 | 4.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.6 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.2 | 0.6 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.2 | 0.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.2 | 0.4 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.2 | 0.6 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 0.6 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.2 | 0.4 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.2 | 1.1 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.2 | 0.6 | GO:1990637 | response to prolactin(GO:1990637) |
0.2 | 0.2 | GO:0072014 | proximal tubule development(GO:0072014) |
0.2 | 0.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 4.1 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.2 | 0.4 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) positive regulation of protein lipidation(GO:1903061) |
0.2 | 0.6 | GO:0010607 | negative regulation of cytoplasmic mRNA processing body assembly(GO:0010607) |
0.2 | 0.9 | GO:0007567 | parturition(GO:0007567) |
0.2 | 0.9 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.2 | 0.9 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.2 | 0.7 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.2 | 0.5 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.2 | 0.4 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.2 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.2 | 1.1 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.2 | 0.4 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.2 | 0.7 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.2 | 3.6 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.2 | 0.7 | GO:0030047 | actin modification(GO:0030047) |
0.2 | 0.9 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.2 | 0.7 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.2 | 0.4 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.2 | 1.9 | GO:0021817 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
0.2 | 1.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.2 | 1.6 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.2 | 0.9 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.2 | 1.4 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.2 | 0.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.2 | 0.3 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.5 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.2 | 0.9 | GO:0045007 | depurination(GO:0045007) |
0.2 | 0.2 | GO:0006113 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
0.2 | 1.0 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.2 | 0.2 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.2 | 1.2 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.2 | 1.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 0.5 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.9 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 0.3 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.2 | 1.5 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.2 | 2.2 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.2 | 0.5 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.2 | 1.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 0.5 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.2 | 3.1 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.2 | 1.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.5 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.2 | 7.6 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.2 | 0.5 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.2 | 0.2 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.2 | 0.5 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 1.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 2.6 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.2 | 1.9 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.6 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.2 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.2 | 0.8 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 0.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 0.8 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.2 | 0.8 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.2 | 0.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 0.5 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
0.2 | 1.9 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.2 | 0.9 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.2 | 0.3 | GO:0043385 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.2 | 4.9 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.2 | 3.9 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 0.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.5 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
0.2 | 0.6 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.2 | 0.2 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
0.2 | 0.2 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.2 | 0.5 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
0.2 | 0.2 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.2 | 2.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 2.9 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 0.4 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
0.1 | 1.2 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.4 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.1 | 0.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.4 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.1 | 0.7 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 2.5 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.1 | 0.3 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.1 | 0.1 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
0.1 | 1.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.1 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.1 | 0.4 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.1 | 0.9 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.7 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.1 | 0.7 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.1 | 0.3 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.1 | 0.7 | GO:0006404 | RNA import into nucleus(GO:0006404) |
0.1 | 0.3 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 1.6 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.4 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.1 | 1.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.3 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.1 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.1 | 0.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.1 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.1 | 0.4 | GO:0006562 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
0.1 | 1.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 0.7 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.1 | 1.0 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.1 | 0.4 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.1 | 2.7 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.3 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
0.1 | 1.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.3 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.1 | 0.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.1 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.1 | 2.3 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.4 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
0.1 | 0.5 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.3 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.1 | 1.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.4 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.1 | 0.7 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 18.0 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 0.5 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.1 | 0.1 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.1 | 0.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.5 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 0.5 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.1 | 1.2 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.1 | 2.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.7 | GO:0070836 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.1 | 0.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 1.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.6 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 1.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.1 | 2.6 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 0.1 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.1 | 1.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.5 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 1.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.1 | 0.3 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.1 | 0.5 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 1.8 | GO:0007129 | synapsis(GO:0007129) |
0.1 | 0.5 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.1 | 1.1 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 1.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 1.4 | GO:2000347 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) positive regulation of hepatocyte proliferation(GO:2000347) |
0.1 | 2.7 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.1 | 0.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 0.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 2.9 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.4 | GO:1903347 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 5.3 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.1 | 0.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.1 | GO:0044691 | tooth eruption(GO:0044691) |
0.1 | 0.8 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.1 | 4.1 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 6.1 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 0.7 | GO:0019640 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
0.1 | 0.8 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 3.7 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.4 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.9 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 1.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.9 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 1.2 | GO:0061744 | motor behavior(GO:0061744) |
0.1 | 0.7 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) |
0.1 | 0.4 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.1 | 1.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.3 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.1 | 0.6 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.1 | 0.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 1.4 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.2 | GO:1905206 | positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.1 | 0.2 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.1 | 0.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 1.4 | GO:0035268 | protein mannosylation(GO:0035268) |
0.1 | 1.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.5 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.1 | 0.2 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.8 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.9 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 2.1 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 2.0 | GO:0006506 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.8 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.5 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.9 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 6.6 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.1 | 0.4 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.4 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.1 | 1.5 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 1.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.6 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.2 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
0.1 | 0.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.6 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.4 | GO:1902916 | regulation of protein polyubiquitination(GO:1902914) positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 3.2 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 0.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.5 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 3.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.3 | GO:0060896 | neural plate pattern specification(GO:0060896) |
0.1 | 0.1 | GO:0034756 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) response to iron ion starvation(GO:1990641) |
0.1 | 4.0 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
0.1 | 0.8 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.4 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 0.5 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 1.4 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 0.6 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.5 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.1 | 0.4 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.1 | 2.4 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.1 | 0.2 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.1 | 1.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.1 | 1.0 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 0.9 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 3.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.3 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.1 | 0.9 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.7 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.1 | 2.5 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 6.2 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.4 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.1 | 0.5 | GO:0034486 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) |
0.1 | 0.5 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.1 | 0.3 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.4 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.1 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.1 | 1.6 | GO:0061082 | myeloid leukocyte cytokine production(GO:0061082) |
0.1 | 0.2 | GO:2000307 | tumor necrosis factor (ligand) superfamily member 11 production(GO:0072535) regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000307) |
0.1 | 1.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.9 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.8 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
0.1 | 0.8 | GO:1902884 | positive regulation of response to oxidative stress(GO:1902884) |
0.1 | 0.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.8 | GO:0051135 | positive regulation of NK T cell activation(GO:0051135) |
0.1 | 0.3 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
0.1 | 0.1 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.3 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.1 | 0.6 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.3 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.1 | 1.8 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 1.0 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.7 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.2 | GO:0051940 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.1 | 1.8 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 2.9 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.3 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
0.1 | 0.3 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
0.1 | 1.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.4 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.2 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.8 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.1 | 0.2 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.1 | 2.0 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.1 | 1.7 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.3 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.1 | 0.1 | GO:0072248 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.1 | 1.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.2 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.1 | 1.9 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.3 | GO:0006788 | heme oxidation(GO:0006788) |
0.1 | 1.3 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 2.6 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.2 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.4 | GO:1901563 | response to camptothecin(GO:1901563) |
0.1 | 1.3 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.1 | 0.8 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 1.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.2 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.1 | 0.2 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.1 | 0.5 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.3 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 1.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.1 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
0.1 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 2.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.1 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 | 0.2 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
0.1 | 0.2 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.3 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.5 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.1 | 0.4 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 0.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.2 | GO:0030002 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
0.1 | 0.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 1.1 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 0.4 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 1.4 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 1.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.1 | 0.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.1 | GO:0050975 | sensory perception of touch(GO:0050975) detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
0.1 | 1.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 3.3 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.2 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.1 | 0.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.1 | 0.1 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.1 | 0.3 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.1 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.1 | 1.2 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.1 | 0.9 | GO:0097009 | energy homeostasis(GO:0097009) |
0.1 | 1.4 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.1 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 0.4 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.6 | GO:0014809 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.1 | 1.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.4 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.1 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.1 | 0.5 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.1 | GO:0051958 | methotrexate transport(GO:0051958) |
0.1 | 0.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.2 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 1.5 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.3 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.1 | 2.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 1.6 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 0.3 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
0.1 | 1.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.9 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.1 | 0.5 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.1 | 0.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.5 | GO:0061709 | reticulophagy(GO:0061709) |
0.1 | 0.7 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.3 | GO:0002357 | defense response to tumor cell(GO:0002357) |
0.1 | 0.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 1.7 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.1 | 0.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.3 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.2 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.1 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 1.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.2 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.1 | 0.4 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 0.2 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.1 | 0.5 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
0.1 | 1.9 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.5 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.3 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) |
0.1 | 1.1 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.1 | 0.1 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
0.1 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 1.5 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.1 | 0.9 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.1 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 0.1 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.1 | 0.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 0.1 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 1.5 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 0.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.2 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 0.2 | GO:0015866 | ADP transport(GO:0015866) |
0.1 | 0.5 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.1 | 0.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 1.0 | GO:0072538 | T-helper 17 type immune response(GO:0072538) |
0.1 | 0.2 | GO:0015858 | nucleoside transport(GO:0015858) adenine nucleotide transport(GO:0051503) |
0.1 | 0.2 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.3 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 1.3 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.7 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.3 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 0.2 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.1 | 1.6 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.4 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.1 | 0.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.6 | GO:0051412 | response to corticosterone(GO:0051412) |
0.1 | 2.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 8.3 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.2 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.1 | 1.1 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.0 | 0.0 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.1 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.2 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 4.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.1 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.0 | 0.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.0 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.1 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.2 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
0.0 | 0.4 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.4 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.0 | 0.3 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.0 | 4.0 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.5 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 2.4 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.1 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.0 | 0.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.2 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.0 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.0 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.0 | 0.4 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.1 | GO:0035261 | external genitalia morphogenesis(GO:0035261) |
0.0 | 0.2 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.2 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.0 | 0.5 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.3 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.0 | 0.1 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.0 | 0.5 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.1 | GO:0099542 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.0 | 0.5 | GO:0036309 | protein localization to M-band(GO:0036309) |
0.0 | 0.5 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 0.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.0 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.0 | 0.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.7 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.0 | 0.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.2 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
0.0 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.1 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.0 | 0.2 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.1 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.0 | 0.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.0 | 0.6 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.1 | GO:0071422 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.2 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.0 | 0.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.3 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.0 | 1.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.2 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.0 | 0.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 1.1 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.1 | GO:0002818 | intracellular defense response(GO:0002818) |
0.0 | 0.2 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.1 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.0 | 0.1 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.0 | 0.4 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.1 | GO:2000721 | pilomotor reflex(GO:0097195) positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.9 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 1.0 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.0 | 0.1 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.0 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.1 | GO:1903259 | exon-exon junction complex disassembly(GO:1903259) |
0.0 | 0.2 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.0 | 0.1 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.0 | 0.1 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.1 | GO:0072679 | thymocyte migration(GO:0072679) |
0.0 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.1 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.0 | 0.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.0 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.3 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
0.0 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.6 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.1 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) |
0.0 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.2 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.0 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.4 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 0.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.2 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.4 | GO:0002369 | T cell cytokine production(GO:0002369) |
0.0 | 0.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.0 | 0.1 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.0 | 0.3 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.1 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
0.0 | 0.1 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.0 | 0.2 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.1 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.0 | 0.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.1 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.0 | 0.1 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.0 | 0.3 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) vitamin K metabolic process(GO:0042373) |
0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) protein localization to cell junction(GO:1902414) |
0.0 | 0.1 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.0 | 0.5 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 1.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.1 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.0 | 0.0 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.1 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
0.0 | 0.1 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) telomere maintenance via base-excision repair(GO:0097698) |
0.0 | 0.2 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.0 | 0.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.3 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.0 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.5 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.1 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.0 | 0.2 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.0 | 0.1 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.0 | 0.0 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.0 | 0.5 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.0 | GO:0021678 | third ventricle development(GO:0021678) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.2 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.6 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.0 | 0.0 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.0 | 0.0 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.0 | 0.2 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.4 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 2.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.0 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
0.0 | 0.0 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.0 | 0.0 | GO:0071874 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
0.0 | 0.1 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.6 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.2 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.0 | 0.2 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.0 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.0 | 0.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.1 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.0 | 0.0 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.0 | 0.0 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.0 | 0.1 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.0 | 0.1 | GO:1900272 | negative regulation of long-term synaptic potentiation(GO:1900272) |
0.0 | 0.0 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) |
0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.1 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.1 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.1 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.0 | 0.0 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.0 | 0.3 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.0 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.0 | 0.0 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.0 | 0.1 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 | 0.1 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.0 | 0.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.1 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.3 | GO:0046456 | icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.0 | 0.0 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.0 | 2.2 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.1 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.0 | 0.1 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.0 | 0.0 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.0 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.0 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.0 | 0.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.0 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.0 | 0.0 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 8.7 | GO:0032449 | CBM complex(GO:0032449) |
1.5 | 7.3 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
1.4 | 4.1 | GO:0055028 | cortical microtubule(GO:0055028) |
1.3 | 13.0 | GO:0097443 | sorting endosome(GO:0097443) |
1.2 | 30.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.0 | 4.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.8 | 8.9 | GO:0005955 | calcineurin complex(GO:0005955) |
0.8 | 2.4 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.8 | 2.3 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.8 | 3.0 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.7 | 15.8 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.7 | 3.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.7 | 3.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.6 | 3.2 | GO:0097513 | myosin II filament(GO:0097513) |
0.6 | 2.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.6 | 1.9 | GO:0043293 | apoptosome(GO:0043293) |
0.6 | 0.6 | GO:1902710 | GABA receptor complex(GO:1902710) |
0.6 | 3.6 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.6 | 2.3 | GO:0039714 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.6 | 2.2 | GO:0097196 | Shu complex(GO:0097196) |
0.5 | 11.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 3.7 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.5 | 14.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.5 | 5.0 | GO:0016589 | NURF complex(GO:0016589) |
0.5 | 1.0 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.5 | 1.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.5 | 1.5 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.5 | 2.9 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.5 | 5.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.5 | 2.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 1.3 | GO:0031251 | PAN complex(GO:0031251) |
0.4 | 0.9 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
0.4 | 1.7 | GO:0044393 | microspike(GO:0044393) |
0.4 | 7.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 1.2 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.4 | 2.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.4 | 4.4 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.4 | 0.8 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.4 | 1.2 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.4 | 4.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 2.8 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.4 | 1.2 | GO:0044753 | amphisome(GO:0044753) |
0.4 | 23.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.4 | 1.5 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.4 | 2.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.4 | 3.4 | GO:0071546 | pi-body(GO:0071546) |
0.4 | 5.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 4.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.4 | 2.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 1.4 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.4 | 2.5 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.4 | 3.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 1.7 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.3 | 1.7 | GO:0001940 | male pronucleus(GO:0001940) |
0.3 | 3.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.3 | 1.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 2.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 1.6 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.3 | 3.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 5.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 1.9 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 9.2 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 1.9 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.3 | 4.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.3 | 2.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.3 | 6.0 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 12.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 0.9 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.3 | 3.0 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.3 | 8.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 0.6 | GO:0014802 | terminal cisterna(GO:0014802) |
0.3 | 2.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 2.0 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 11.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 6.4 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.3 | 0.6 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.3 | 0.6 | GO:0034657 | GID complex(GO:0034657) |
0.3 | 19.0 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 4.9 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 0.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.3 | 2.1 | GO:0035976 | AP1 complex(GO:0035976) |
0.3 | 1.3 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.3 | 1.5 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.3 | 0.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.3 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 1.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 0.8 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.3 | 2.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 1.5 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.2 | 3.5 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 9.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 3.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 4.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 1.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 2.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 2.8 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 1.4 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.2 | 0.5 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.2 | 0.7 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 3.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 4.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 0.9 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.2 | 1.7 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.2 | 1.1 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.2 | 0.8 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 7.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 7.5 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.2 | 0.8 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 0.4 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.2 | 2.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 19.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 1.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 1.5 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.4 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.2 | 0.6 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.2 | 7.5 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 9.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 0.4 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 0.6 | GO:1905103 | integral component of lysosomal membrane(GO:1905103) |
0.2 | 1.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 0.4 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 0.9 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.2 | 0.9 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 3.2 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 28.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 1.1 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 6.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 1.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.2 | 1.7 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 1.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.2 | 0.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.2 | 2.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.2 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 1.5 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 20.9 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 0.7 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.2 | 1.5 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 3.6 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.2 | 1.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 0.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.2 | 11.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 7.0 | GO:0099738 | cell cortex region(GO:0099738) |
0.2 | 5.6 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 2.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 1.5 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 1.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 4.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.4 | GO:1990917 | sperm head plasma membrane(GO:1990913) ooplasm(GO:1990917) |
0.1 | 5.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.9 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 4.3 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 3.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.8 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.1 | 11.5 | GO:0031672 | A band(GO:0031672) |
0.1 | 0.9 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 0.9 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 2.1 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.7 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.1 | 0.8 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 1.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 7.3 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.4 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.1 | 1.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 6.4 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.6 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 3.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 1.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 1.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 2.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.9 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 0.1 | GO:0005816 | spindle pole body(GO:0005816) |
0.1 | 1.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 1.3 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 1.0 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 14.8 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 1.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.7 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.1 | 1.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 1.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.3 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.1 | 1.7 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.4 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.1 | 1.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 1.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 1.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 1.1 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.7 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.5 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.1 | 2.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 1.7 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.1 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 5.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.5 | GO:0032302 | MutSbeta complex(GO:0032302) |
0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 2.6 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.8 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 1.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.8 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 2.6 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 3.7 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 1.2 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.4 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.1 | 0.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 1.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 2.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 5.5 | GO:0035579 | specific granule membrane(GO:0035579) |
0.1 | 2.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.1 | 0.1 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.1 | 2.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.3 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.1 | 0.3 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.1 | 5.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 3.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 15.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 4.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.5 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 3.5 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 1.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.1 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.1 | 1.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.3 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.1 | 0.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 1.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.3 | GO:0044307 | dendritic branch(GO:0044307) |
0.1 | 2.4 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 6.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 43.9 | GO:0005912 | adherens junction(GO:0005912) |
0.1 | 1.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 20.7 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.3 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.3 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 1.5 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 2.9 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 0.6 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 1.1 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 0.9 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 0.7 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 2.3 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.2 | GO:0097545 | axonemal outer doublet(GO:0097545) |
0.1 | 0.9 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.2 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 0.1 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.1 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 2.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.2 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 1.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0001534 | radial spoke(GO:0001534) |
0.0 | 0.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 3.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.0 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.2 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.0 | 1.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.2 | GO:0071920 | cleavage body(GO:0071920) |
0.0 | 1.3 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.1 | GO:0032116 | SMC loading complex(GO:0032116) |
0.0 | 0.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 12.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 0.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 2.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.0 | 0.2 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.0 | 0.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.0 | 0.0 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.0 | 0.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.0 | 0.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.1 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
0.0 | 0.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.0 | 0.0 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.0 | 0.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.2 | GO:1990630 | IRE1-RACK1-PP2A complex(GO:1990630) |
0.0 | 0.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 0.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 3.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.3 | GO:0005688 | U6 snRNP(GO:0005688) |
0.0 | 1.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.1 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.0 | 0.1 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.2 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.0 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.1 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.0 | 0.1 | GO:0048500 | signal recognition particle(GO:0048500) |
0.0 | 0.9 | GO:0019814 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.1 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 1.0 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 3.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 2.3 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.7 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.6 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 1.4 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 1.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 21.8 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
2.1 | 8.4 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
1.8 | 1.8 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.8 | 7.1 | GO:0047291 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
1.7 | 5.2 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
1.7 | 5.1 | GO:0046577 | long-chain-alcohol oxidase activity(GO:0046577) |
1.7 | 10.0 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
1.6 | 6.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.6 | 12.8 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
1.6 | 6.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.5 | 12.2 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.4 | 12.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.2 | 14.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.2 | 21.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.2 | 4.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.1 | 5.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.1 | 7.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.0 | 6.3 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
1.0 | 6.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.0 | 4.2 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
1.0 | 3.0 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
1.0 | 4.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.0 | 4.0 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
1.0 | 4.0 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
1.0 | 4.9 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.0 | 3.9 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.0 | 6.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
1.0 | 2.9 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
1.0 | 5.7 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.9 | 7.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.9 | 2.8 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.9 | 8.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.9 | 5.4 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.9 | 6.3 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.9 | 4.5 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.9 | 2.6 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.8 | 12.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.8 | 6.5 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.8 | 3.1 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
0.8 | 2.3 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.8 | 2.3 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
0.7 | 3.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.7 | 14.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.7 | 3.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.7 | 2.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.7 | 2.9 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.7 | 2.2 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.7 | 2.9 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.7 | 2.9 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
0.7 | 2.8 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.7 | 5.6 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.7 | 2.8 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.7 | 6.9 | GO:0071253 | connexin binding(GO:0071253) |
0.7 | 7.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.7 | 3.4 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.7 | 2.7 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
0.7 | 2.0 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.6 | 1.9 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.6 | 5.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.6 | 1.9 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.6 | 1.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.6 | 1.9 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.6 | 1.9 | GO:0061697 | protein-malonyllysine demalonylase activity(GO:0036054) protein-succinyllysine desuccinylase activity(GO:0036055) protein-glutaryllysine deglutarylase activity(GO:0061697) |
0.6 | 3.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.6 | 1.9 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.6 | 1.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.6 | 2.4 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.6 | 12.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.6 | 3.0 | GO:1903135 | cupric ion binding(GO:1903135) |
0.6 | 1.8 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.6 | 1.8 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.6 | 9.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.6 | 0.6 | GO:0031753 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
0.6 | 3.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.6 | 3.5 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.6 | 13.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.6 | 3.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.6 | 0.6 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.6 | 2.8 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.5 | 2.2 | GO:0047708 | biotinidase activity(GO:0047708) |
0.5 | 2.7 | GO:0003896 | DNA primase activity(GO:0003896) |
0.5 | 1.6 | GO:0008940 | nitrate reductase activity(GO:0008940) molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
0.5 | 5.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.5 | 1.6 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.5 | 16.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.5 | 1.6 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
0.5 | 9.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.5 | 4.2 | GO:0005534 | galactose binding(GO:0005534) |
0.5 | 2.6 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.5 | 3.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.5 | 1.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.5 | 2.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.5 | 0.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.5 | 3.3 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.5 | 1.4 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.5 | 1.4 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.5 | 1.4 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.5 | 1.4 | GO:0008903 | hydroxypyruvate isomerase activity(GO:0008903) |
0.5 | 2.7 | GO:0039552 | RIG-I binding(GO:0039552) |
0.5 | 1.8 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.5 | 0.9 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.5 | 5.9 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.4 | 1.8 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.4 | 3.5 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.4 | 3.0 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.4 | 0.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.4 | 3.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 10.7 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.4 | 1.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.4 | 1.3 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.4 | 3.4 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.4 | 0.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.4 | 1.3 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.4 | 1.7 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
0.4 | 13.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.4 | 2.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.4 | 1.2 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
0.4 | 15.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.4 | 1.2 | GO:0047750 | cholestenol delta-isomerase activity(GO:0047750) |
0.4 | 0.4 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.4 | 1.2 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.4 | 1.2 | GO:0005055 | laminin receptor activity(GO:0005055) |
0.4 | 4.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.4 | 1.2 | GO:0031626 | beta-endorphin binding(GO:0031626) |
0.4 | 2.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.4 | 0.8 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.4 | 1.6 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.4 | 2.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.4 | 1.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 1.2 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.4 | 4.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.4 | 2.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 3.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 0.4 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.4 | 1.5 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.4 | 1.5 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.4 | 1.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.4 | 1.9 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.4 | 0.4 | GO:0001003 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.4 | 1.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.4 | 6.4 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.4 | 1.9 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.4 | 4.8 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.4 | 10.3 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 2.2 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.4 | 4.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 3.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 4.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.4 | 7.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.4 | 1.8 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.4 | 4.3 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.4 | 1.1 | GO:0016717 | C-5 sterol desaturase activity(GO:0000248) oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) sterol desaturase activity(GO:0070704) |
0.4 | 0.7 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.4 | 0.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.4 | 1.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.4 | 3.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.3 | 4.5 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.3 | 1.7 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.3 | 2.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.3 | 1.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 1.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 0.3 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
0.3 | 1.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.3 | 1.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.3 | 1.7 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.3 | 1.0 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
0.3 | 3.6 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.3 | 2.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.3 | 1.0 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.3 | 3.9 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 1.6 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
0.3 | 2.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 1.3 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.3 | 1.0 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.3 | 1.0 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.3 | 0.9 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 3.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.3 | 0.9 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.3 | 0.9 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.3 | 1.2 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.3 | 0.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.3 | 5.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 1.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 0.9 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
0.3 | 1.5 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.3 | 1.2 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.3 | 1.8 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.3 | 0.9 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.3 | 0.9 | GO:0090541 | MIT domain binding(GO:0090541) |
0.3 | 5.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 2.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 3.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.3 | 0.9 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.3 | 2.6 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 1.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.3 | 0.9 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 2.9 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.3 | 2.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 4.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 1.4 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.3 | 2.0 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.3 | 2.8 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.3 | 0.8 | GO:0070404 | NADH binding(GO:0070404) |
0.3 | 2.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.3 | 2.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 1.9 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 0.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 1.4 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.3 | 1.1 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.3 | 7.1 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 2.2 | GO:0015923 | mannosidase activity(GO:0015923) |
0.3 | 1.6 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 1.6 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 0.8 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.3 | 9.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 1.3 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.3 | 1.0 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.3 | 1.6 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 2.3 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.3 | 0.3 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.3 | 1.0 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.3 | 2.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 1.0 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.3 | 8.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.3 | 3.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 1.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 1.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 0.7 | GO:0016497 | substance K receptor activity(GO:0016497) |
0.2 | 1.2 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.2 | 0.5 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
0.2 | 7.7 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.2 | 5.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 3.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 1.0 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
0.2 | 6.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 0.7 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 2.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.7 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.2 | 10.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 0.5 | GO:0070538 | oleic acid binding(GO:0070538) |
0.2 | 0.9 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.2 | 31.7 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.2 | 0.7 | GO:0051717 | inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity(GO:0051717) |
0.2 | 0.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 2.3 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.2 | 0.9 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.2 | 2.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 0.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 0.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 1.8 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 2.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 0.7 | GO:0017129 | triglyceride binding(GO:0017129) |
0.2 | 6.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 0.7 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 0.7 | GO:0003860 | 3-hydroxyisobutyryl-CoA hydrolase activity(GO:0003860) |
0.2 | 5.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 1.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 5.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.8 | GO:0004078 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
0.2 | 1.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.6 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
0.2 | 0.6 | GO:0032428 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
0.2 | 2.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 3.1 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.2 | 0.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 0.6 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
0.2 | 1.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.2 | 1.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 0.8 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.2 | 0.8 | GO:0043273 | CTPase activity(GO:0043273) |
0.2 | 1.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 6.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.6 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.2 | 0.8 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 3.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 2.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 1.6 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.2 | 0.6 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.2 | 1.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 0.8 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 3.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 4.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.2 | 1.0 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.2 | 1.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 2.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.2 | 0.6 | GO:0052830 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
0.2 | 1.1 | GO:0052844 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.2 | 0.6 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.2 | 15.0 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 0.4 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.2 | 1.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 1.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.2 | 0.5 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.2 | 1.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 0.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.5 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.2 | 2.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 1.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.2 | 0.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 3.7 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.2 | 0.5 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
0.2 | 0.7 | GO:0004146 | dihydrofolate reductase activity(GO:0004146) |
0.2 | 2.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.4 | GO:0016890 | site-specific endodeoxyribonuclease activity, specific for altered base(GO:0016890) |
0.2 | 78.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.2 | 1.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 5.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 3.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 0.2 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.2 | 1.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 2.0 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 0.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 0.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 1.7 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 1.2 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.2 | 5.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 0.7 | GO:0045569 | TRAIL binding(GO:0045569) |
0.2 | 0.8 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.2 | 0.8 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.2 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 1.0 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.2 | 0.7 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 1.5 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.2 | 1.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 2.9 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 2.4 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 1.6 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.5 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
0.2 | 2.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.9 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 1.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 2.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.6 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.2 | 0.3 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
0.2 | 0.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 1.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 1.6 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 0.5 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.2 | 0.5 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.2 | 5.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.2 | 0.5 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.2 | 2.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 3.0 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.2 | 2.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 0.5 | GO:0004638 | phosphoribosylaminoimidazole carboxylase activity(GO:0004638) phosphoribosylaminoimidazolesuccinocarboxamide synthase activity(GO:0004639) |
0.2 | 5.0 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 9.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 1.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 3.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.4 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.1 | 0.9 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 0.7 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 3.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.7 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 1.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 2.6 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.6 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.1 | 0.6 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.9 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 1.3 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.1 | 0.4 | GO:0019777 | Atg12 transferase activity(GO:0019777) |
0.1 | 3.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 4.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 1.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.5 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 1.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.4 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.1 | 0.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.5 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.1 | 5.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 1.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 12.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 2.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.5 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 3.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.9 | GO:0009374 | biotin carboxylase activity(GO:0004075) biotin binding(GO:0009374) |
0.1 | 4.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.4 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.6 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.1 | 0.1 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.5 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.1 | 1.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 5.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 2.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.4 | GO:0000252 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity(GO:0047012) |
0.1 | 0.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.6 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.1 | 0.6 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 0.5 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 2.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.2 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 3.5 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.5 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.1 | 0.8 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 0.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.2 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.1 | 0.8 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 1.4 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.1 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.1 | 14.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 3.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 3.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.1 | 0.8 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 5.4 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 24.3 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.1 | 0.3 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.1 | 0.7 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 4.0 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.1 | 0.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.3 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.1 | 7.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 1.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 3.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.3 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.1 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 1.2 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 1.5 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 1.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 2.0 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 2.1 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 0.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.3 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.1 | 0.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.2 | GO:0070330 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) aromatase activity(GO:0070330) |
0.1 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 14.8 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 1.5 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.1 | 0.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 1.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 1.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 1.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.9 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.9 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 3.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 6.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.9 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 6.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 1.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 8.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 2.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 3.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.1 | 1.8 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 1.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.9 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 5.7 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.4 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.1 | 0.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.7 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 1.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.2 | GO:0019144 | ADP-sugar diphosphatase activity(GO:0019144) |
0.1 | 0.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 3.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.3 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.1 | 0.5 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.2 | GO:0000035 | acyl binding(GO:0000035) |
0.1 | 0.2 | GO:0016794 | guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity(GO:0008893) diphosphoric monoester hydrolase activity(GO:0016794) |
0.1 | 0.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.7 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.6 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 3.7 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.2 | GO:0034512 | box C/D snoRNA binding(GO:0034512) |
0.1 | 0.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 1.3 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.2 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.1 | 0.5 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 4.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.2 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.1 | 0.2 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 0.9 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 0.2 | GO:0043035 | chromatin insulator sequence binding(GO:0043035) |
0.1 | 1.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 4.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 0.4 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.1 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.8 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 3.6 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.7 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 3.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 2.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.1 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.5 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 0.1 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.1 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 1.6 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.3 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 1.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 2.4 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 0.3 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.1 | 0.2 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.1 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.2 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.1 | 1.2 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 0.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 1.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 1.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 1.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 2.8 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.1 | 0.2 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 0.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.1 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.1 | 1.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.2 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.4 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.3 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 0.3 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.1 | 0.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 1.2 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.2 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
0.0 | 1.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.3 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.0 | 0.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.2 | GO:0042282 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
0.0 | 0.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 1.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.0 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.0 | 2.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.3 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.0 | 0.3 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.0 | 0.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 1.0 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 1.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.4 | GO:0043295 | glutathione binding(GO:0043295) |
0.0 | 0.2 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.0 | 0.1 | GO:0004040 | amidase activity(GO:0004040) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.2 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 29.2 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.1 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.0 | 0.4 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.1 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.0 | 0.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.3 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 1.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.2 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.4 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.0 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.1 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.0 | 0.1 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.0 | 0.1 | GO:0008431 | vitamin E binding(GO:0008431) |
0.0 | 0.1 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.0 | 0.1 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.0 | 0.4 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.3 | GO:0022821 | potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.0 | 0.1 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.0 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.1 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.0 | 0.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.4 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0052901 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.0 | 0.1 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.0 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.2 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.0 | 2.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.6 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.1 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.0 | 0.1 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.0 | 0.1 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.0 | 0.1 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
0.0 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.2 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.2 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.8 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 2.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 0.0 | GO:0031696 | alpha-2C adrenergic receptor binding(GO:0031696) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.0 | 0.3 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.0 | 0.1 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.0 | 0.1 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.0 | 0.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
0.0 | 0.5 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.0 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 2.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.8 | 13.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.7 | 64.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.7 | 42.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.6 | 7.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.6 | 22.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.6 | 22.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.5 | 0.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.4 | 2.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.4 | 6.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 5.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 4.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 5.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 10.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 0.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 1.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 17.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 11.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 11.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 18.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 9.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 4.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.3 | 3.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 20.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 4.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 5.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 20.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 5.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 4.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 2.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 2.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 2.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 7.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 0.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 3.9 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 4.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 18.5 | PID E2F PATHWAY | E2F transcription factor network |
0.2 | 1.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 2.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 7.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 5.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 1.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 14.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 13.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 2.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 3.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 1.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 3.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.5 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 2.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 5.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 6.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 6.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 2.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 5.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 1.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 2.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 2.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 3.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 2.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 4.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 1.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 2.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.7 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 1.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 1.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 2.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.3 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 29.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.6 | 3.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.6 | 11.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.6 | 10.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.6 | 28.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.6 | 5.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.6 | 8.6 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.5 | 2.6 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.5 | 6.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 1.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.5 | 0.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 3.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.4 | 10.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 9.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.4 | 8.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.4 | 15.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.4 | 9.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.4 | 25.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 1.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.4 | 12.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 13.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 5.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.3 | 4.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 0.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 0.3 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.3 | 5.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 7.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 6.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 6.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.3 | 8.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.3 | 3.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.3 | 7.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 9.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.3 | 8.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 0.3 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.3 | 10.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.3 | 5.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.3 | 4.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 2.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 3.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 4.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 5.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 2.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 5.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 4.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 4.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 11.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 7.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 19.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 1.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 5.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 0.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 5.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 12.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 2.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 1.0 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.2 | 2.9 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.2 | 0.4 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.2 | 5.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 1.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 3.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 2.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 3.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.2 | 0.7 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.2 | 0.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 5.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 1.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 3.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 2.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 1.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 1.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 2.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 1.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 4.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 0.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 11.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 15.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 2.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 4.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 14.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 2.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 11.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 7.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 1.7 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 3.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 2.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.8 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 2.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.4 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 4.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 2.7 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 1.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 2.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 1.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 1.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 3.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 4.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 2.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 2.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 3.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 12.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 2.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 3.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.3 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.1 | 2.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 4.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 2.8 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 1.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 1.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 2.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.9 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 0.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 1.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 2.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 1.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 3.1 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 3.2 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.8 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 1.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 2.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 2.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.5 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 2.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |